Development and validation of an allele-specific PCR assay for genotyping a promoter and exonic single nucleotide polymorphisms of MGMT gene

Main Article Content

Anuj Kumar Tyagi
Mary Boudal Khoshbeen
Patricia Huezo-Diaz Curtis
Chakradhara Rao S. Uppugunduri
Marc Ansari

Keywords

allele-specific PCR, exon, MGMT, rs2308321, rs113813075, genotyping

Abstract

DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) specifically remove the methyl/alkyl group from the O6-position of guanine and restore the guanine to its normal form without causing DNA strand breaks. Relationship between MGMT activity and resistance to alkylating therapeutic agents is well established. Non-availability of simple, cost-effective and efficient methods of genotyping may hinder investigations on genotype-phenotype associations. No simple genotyping procedures such as allele-discrimination Taqman Assays were available for two genetic variations in MGMT gene that had previously demonstrated to be affecting its function and expression.These two variants were included to genotype in a clinical study (Clinicaltrail.gov ID: NCT01257854). Hence, the present study is aimed at developing,   validating a rapid and simple allele-specific PCR method that genotypes exonic variant rs2308321 (c.520A>G) and a promoter variant rs113813075 (c.-459C>A) with standard PCR instruments.Web-based allele-specific (AS) primer design application called web-based allele-specific primer was used to design primers. Genomic DNA of lymphoblastoid cell line obtained from the Coriell repository with known genotypes were used to standardize the genotyping procedure. The PCR products were analyzed by 3% Agarose gel electrophoresis and by DNA Screen Tape assay with the Agilent 4200 TapeStation. The allele-specific PCR assay described here is a suitable strategy for efficient and reliable genotyping for difficult variants. This method offers cost-effective strategy for genotyping in clinical cohort studies provided positive controls established by Sanger sequencing are available for the variant. 

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
Abstract 44 | HTML Downloads 271 PDF Downloads 172 Supplementary information Downloads 0

References

1) Natarajan AT, Vermeulen S, Darroudi F, Valentine MB, Brent TP, et al. (1992) Chromosomal localization of human O6-methylguanine-DNA methyltransferase (MGMT) gene by in situ hybridization. Mutagenesis 7: 83-85.
2) Anthony EP, Qingming F and Natalia AL (2007) Human variants of O6-alkylguanine-DNA alkyltransferase. DNA Repair 6(8): 1071-1078.
3) Julie LT, Anthony EP and John AT (2007) DNA binding, nucleotide flipping, and the helix-turn-helix motif in base repair by O6-alkylguanine-DNA alkyltransferase and its implications for cancer chemotherapy. DNA Repair 6(8): 1100-1115.
4) James MB, Jiali H, Miaw ST, David JH, Leona DS (2007) Genetic association and functional studies of major polymorphic variants of MGMT. DNA Repair 6: 1116-1126.
5) Yet HL, Panagiota NM, Richard B, Angela W, Hannah J et al. (2010) MGMT Ile143Val polymorphism, dietary factors and the risk of breast, colorectal and prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk study. DNA Repair 9: 421-428.
6) Sylvester RK, Steen P, Tate JM, Mehta M, Petrich RJ et al. (2011) Temozolomide-induced severe myelosuppression: analysis of clinically associated polymorphisms in two patients. Anticancer Drugs 22(1): 104-110.
7) Guo H, Bassig BA, Lan Q, Zhu Y, Zhang Y et al. (2014) Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma. Cancer Causes Control 25(10): 1261-1270.
8) Dubois J, Etienne G, Laroche-Clary A, Lascaux A, Bidet A et al. (2014) Identification of methylguanine methyltransferase polymorphisms as genetic markers of individual susceptibility to therapy-related myeloid neoplasms. Eur J Cancer 50(2): 418-424.
9) Costello JF, Futscher BW, Kroes RA, Pieper RO. (1994) Methylation-related chromatin structure is associated with exclusion of transcription factors from and suppressed expression of the O6-methylguanine DNA methyltransferase gene in human glioma cell lines. Mol Cell Biol 14(10): 6515-6521.
10) Meixiang X, Ilona N, Courtney EC, Catherine MR, Jeffrey KW and Sherif ZAR. (2014) Influence of promoter/enhancer region haplotypes on MGMT transcriptional regulation: a potential biomarker for human sensitivity to alkylating agents. Carcinogenesis 35(3): 564-571.
11) Gut IG (2001) Automation in genotyping of single nucleotide polymorphisms. Hum Mutat 17: 475-492.
12) Wu DY, Ugozzoli L, Pal BK, Wallace RB (1989) Allele-specific enzymatic amplification of beta-globin genomic DNA for diagnosis of sickle cell anemia. Proc Natl Acad Sci U S A 86: 2757-2760.
13) Pongsakorn W, Kridsadakorn C, Chumpol N, Uttapong R, Juntima C et al. (2007) WASP: a Web-based Allele-Specific PCR assay designing tool for detecting SNPs and mutations. BMC Genomics 8: 275-283.
14) The 1000 Genomes Project Consortium. (2015) A global reference for human genetic variation. Nature 526: 68-74.
15) Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein-E by gene amplification and cleavage with Hhal. J Lipid Res 31: 545-548.
16) Koch W, Ehrenhaft A, Griesser K, Pfeufer A, Müller J et al. (2002) TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein-E. Clin Chem Lab Med 40: 1123-1131.
17) Aydin A, Toliat MR, Bähring S, Becker C, Nürnberg P (2006) New universal primers facilitate pyrosequencing. Electrophoresis 27: 394-397.